News & Events

In the news

Congress

Meet our teams at CPHI Worldwide

Meet the teams from companies Clean Cells & Naobios next November as they attend CPHI Worldwide.

Collaboration

Naobios manufactures FluGen Inc’s M2SR influenza vaccine candidate for upcoming clinical trials

Naobios’ development work and GMP manufacturing of vaccine clinical batches will enable FluGen to prepare its 2022 clinical trials in the United States.

Portrait : Séverine Leroy

Head of PMO (Project Manager Office) at Naobios

Because Naobios is above all a human adventure at the service of Human, we invite you to discover the portrait of one of its experts, Séverine Leroy, her background and her missions as Head of Project Manager Office.

Webinar in association with Polepharma

« Vaccine: Biomanufacturing and quality control testing challenges »

The theme of this new webinar will be « Vaccine: Biomanufacturing and quality control testing challenges » and will take place on 27th May 2021, in association with POLEPHARMA.

Enregistrement webinaire Naobios

Our webinar is now available for replay!

« Bioprocess development challenges: microcarrier process development and scale up ».

You will find below the youtube link to our latest webinar "Bioprocess development challenges: microcarrier based process development and scale up" co-hosted by Luis RAIADO and Juliette AMBROSINI. An opportunity to watch and share the online event from 15 April!

Bioprocess development webinar

Tackling challenges in Development and scale-up of Virus and Vaccine Manufacturing Processes using microcarriers.

Save the date, our next webinar will take place on April 15th! Join Luís Raiado and Juliette Ambrosini next month for a brand-new edition tackling challenges posed by microcarrier-based processes in bioprocess development and scale-up.

New in the lab

New Bioreactors on Process Development – Increasing flexibility and capacity

To continuously improve Process Development, Naobios acquired three new bioreactor control systems which increase flexibility and capacity and rely on independent monitoring and control of vessels up to 40 L.

BSL3 manufacturing area

Naobios opens a new BioSafety Level 3 manufacturing unit

Naobios is pleased to announce the opening of a new 110m2 BSL3 manufacturing area, following major revamping of the facility.